Literature DB >> 19472401

The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers.

Daiji Oka1, Satoshi Yamashita, Tadashi Tomioka, Yukihiro Nakanishi, Hoichi Kato, Michio Kaminishi, Toshikazu Ushijima.   

Abstract

BACKGROUND: Esophageal squamous cell carcinomas (ESCCs) tend to have multiple primary lesions, and it is believed that they arise from background mucosae with accumulation of genetic/epigenetic alterations. In this study, the objective was to elucidate the effects of smoking and drinking on the accumulation of epigenetic alterations in background mucosae.
METHODS: Genes that are silenced in human ESCCs were searched for by treating 3 ESCC cell lines with the demethylating agent, 5-aza-2'-deoxycytidine and performing oligonucleotide microarrays. Methylation levels were analyzed by quantitative methylation-specific polymerase chain reaction analysis of 60 ESCCs and their corresponding background mucosae.
RESULTS: Forty-seven genes were identified as methylation-silenced in at least 1 of the 3 ESCC cell lines, and 14 of those genes (claudin 6 [CLDN6]; G protein-coupled receptor 158 [GPR158]; homeobox A9 [HOXA9]; metallothionein 1M [MT1M]; neurofilament, heavy polypeptide 200 kDa [NEFH]; plakophilin 1 [PKP1]; protein phosphatase 1, regulatory [inhibitor] subunit 14A [PPP1R14A]; pyrin domain and caspase recruitment domain containing [PYCARD]; R-spondin family, member 4 [RSPO4]; testis-specific protein, Y-encoded-like 5 [TSPYL5]; ubiquitin carboxyl-terminal esterase L1 [UCHL1]; zinc-finger protein 42 homolog [ZFP42]; zinc-finger protein interacting with K protein 1 homolog [ZIK1]; and zinc-finger and SCAN domain containing 18 [ZSCAN18]) were used as markers. In the background mucosae, methylation levels of 5 genes (HOXA9, MT1M, NEFH, RSPO4, and UCHL1) had significant correlations with smoking duration (rho=.268; P=.044; rho=.405; P=.002; rho=.285; P=.032; rho=.300; P=.024; and rho=.437; P=.001, respectively). In contrast, an inverse correlation between PYCARD methylation levels and alcohol intake was observed (rho=-.334, P=.025) among individuals with the inactive aldehyde dehydrogenase 2 (ALDH2) genotype.
CONCLUSIONS: The current results suggested that ESCCs developed from an epigenetic field for cancerization, which was induced by exposure to carcinogenic factors, such as tobacco smoking. The epigenetic field defect will be a novel target for risk diagnosis and prevention of ESCCs. Copyright (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19472401     DOI: 10.1002/cncr.24394

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  58 in total

1.  Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma.

Authors:  Jun-Xiong Wang; Yuan-Long He; Sheng-Tao Zhu; Shuo Yang; Shu-Tian Zhang
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Hypermethylation of a cluster of Krüppel-type zinc finger protein genes on chromosome 19q13 in oropharyngeal squamous cell carcinoma.

Authors:  Roberto A Lleras; Leslie R Adrien; Richard V Smith; Benjamin Brown; Naheed Jivraj; Christopher Keller; Cathy Sarta; Nicolas F Schlecht; Thomas M Harris; Geoffrey Childs; Michael B Prystowsky; Thomas J Belbin
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.

Authors:  Yuanlong He; Yongjun Wang; Peng Li; Shengtao Zhu; Junxiong Wang; Shutian Zhang
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

4.  p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma.

Authors:  Asuka Murata; Yoshifumi Baba; Masayuki Watanabe; Hironobu Shigaki; Keisuke Miyake; Ryuichi Karashima; Yu Imamura; Satoshi Ida; Takatsugu Ishimoto; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

Review 5.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

6.  The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands.

Authors:  Hideyuki Takeshima; Satoshi Yamashita; Taichi Shimazu; Tohru Niwa; Toshikazu Ushijima
Journal:  Genome Res       Date:  2009-08-03       Impact factor: 9.043

7.  Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans.

Authors:  Yan V Sun; Alicia K Smith; Karen N Conneely; Qiuzhi Chang; Weiyan Li; Alicia Lazarus; Jennifer A Smith; Lynn M Almli; Elisabeth B Binder; Torsten Klengel; Dorthie Cross; Stephen T Turner; Kerry J Ressler; Sharon L R Kardia
Journal:  Hum Genet       Date:  2013-05-09       Impact factor: 4.132

Review 8.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

9.  Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.

Authors:  Xueping Qiu; Bo Hu; Yifang Huang; Yunte Deng; Xuebin Wang; Fang Zheng
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

10.  Identification of a DNA methylation marker that detects the presence of lymph node metastases of gastric cancers.

Authors:  Yasuyuki Shigematsu; Tohru Niwa; Satoshi Yamashita; Hirokazu Taniguchi; Ryoji Kushima; Hitoshi Katai; Seiji Ito; Tetsuya Tsukamoto; Masao Ichinose; Toshikazu Ushijima
Journal:  Oncol Lett       Date:  2012-05-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.